Quick Answer
China SXT Pharmaceuticals, Inc. reported Long Term Debt of $96.3 thousand for the year ending 2025.
- China SXT Pharmaceuticals, Inc. showed a decrease of -17.8% in Long Term Debt from 2024 to 2025.
- This data is from China SXT Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on July 31, 2025.
- XBRL data for this metric is available from 2019 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2019 to 2025), China SXT Pharmaceuticals, Inc.'s Long Term Debt has grown by 130.8%.
- Historical annual values: Fiscal year 2025: $96.3 thousand | Fiscal year 2024: $117.1 thousand | Fiscal year 2023: $117.9 thousand | Fiscal year 2021: $6.3 thousand | Fiscal year 2020: $36.5 thousand | Fiscal year 2019: $41.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: